The neutralization of IL-9 successfully reversed this effect, suggesting an antitumor role of IL-9 against melanoma, in contrast to previous studies involving hematological cancers (99–101, 108). The gene discussed is IL9; the disease is hematopoietic and lymphoid cell neoplasm.